TheJobsMapShinobi Therapeutics jobs and careers
South San Francisco, United States
About Shinobi Therapeutics
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
Founded in 2023 by Shin Kaneko and Tobias Deuse.
- Founded
- 2023
- Employees
- 11 to 50
- Total funding
- $178M
- Headquarters
- South San Francisco
Leadership
The top of Shinobi Therapeutics's org chart, with how many people report into each leader.
Dan Kemp
Chief Executive Officer
11 reports
Bhanu Iyer
VP US Operations & HR
3 reports
Eiki Maeda
VP, Head of CMC & Manufacturing
1 report
Motonobu Ueno
R&d General Affairs
Alan Jacks
Sr. Manager, Business Development Lead
Masashi Ochi
VP, Head of Program Leadership and Management
Steven Katz
Chief Medical Officer and SVP, Translational Research
Ryosuke Gonotsubo
Chief Of Staff
Jobs at Shinobi Therapeutics
No open positions right now. Explore more companies on TheJobsMap.